Altria shares hit after National Cancer Institute director named acting head of the FDA

Article Link: Altria shares hit after National Cancer Institute director named acting head of the FDA

Altria investors don’t seem to like the prospects for the cigarette maker under the new acting FDA commissioner.

Source: CNN Investing